NHLRC2
Basic information
Region (hg38): 10:113854661-113917194
Links
Phenotypes
GenCC
Source:
- fibrosis, neurodegeneration, and cerebral angiomatosis (Limited), mode of inheritance: AR
- fibrosis, neurodegeneration, and cerebral angiomatosis (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Fibrosis, neurodegeneration, and cerebral angiomatosis | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Allergy/Immunology/Infectious; Cardiovascular; Gastrointestinal; Hematologic; Neurologic; Pulmonary | 29423877 |
ClinVar
This is a list of variants' phenotypes submitted to
- Fibrosis, neurodegeneration, and cerebral angiomatosis (2 variants)
- not provided (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NHLRC2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 6 | |||||
missense | 43 | 47 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 2 | 2 | 44 | 9 | 0 |
Highest pathogenic variant AF is 0.000433
Variants in NHLRC2
This is a list of pathogenic ClinVar variants found in the NHLRC2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-113854873-A-G | Fibrosis, neurodegeneration, and cerebral angiomatosis | Conflicting classifications of pathogenicity (Apr 25, 2022) | ||
10-113854915-C-G | NHLRC2-related disorder | Likely benign (Aug 26, 2024) | ||
10-113854931-C-T | Inborn genetic diseases | Uncertain significance (Feb 27, 2024) | ||
10-113854966-CAGG-C | Fibrosis, neurodegeneration, and cerebral angiomatosis | Uncertain significance (-) | ||
10-113854988-A-G | Inborn genetic diseases | Uncertain significance (Feb 01, 2023) | ||
10-113854991-A-G | Inborn genetic diseases • Fibrosis, neurodegeneration, and cerebral angiomatosis | Conflicting classifications of pathogenicity (Sep 20, 2024) | ||
10-113855020-C-T | Fibrosis, neurodegeneration, and cerebral angiomatosis | Pathogenic (Nov 03, 2021) | ||
10-113855023-G-A | Uncertain significance (May 16, 2024) | |||
10-113855031-A-T | Likely benign (Feb 01, 2024) | |||
10-113858566-T-A | Inborn genetic diseases | Uncertain significance (Oct 12, 2022) | ||
10-113858573-A-T | Fibrosis, neurodegeneration, and cerebral angiomatosis | Pathogenic (Sep 20, 2021) | ||
10-113858593-G-C | Inborn genetic diseases | Uncertain significance (Jan 30, 2024) | ||
10-113858625-CTG-C | See cases | Likely pathogenic (Jun 03, 2020) | ||
10-113876533-T-C | Inborn genetic diseases | Uncertain significance (Nov 12, 2021) | ||
10-113876549-G-A | NHLRC2-related disorder | Likely benign (Apr 16, 2024) | ||
10-113876567-A-G | Likely benign (Jun 01, 2022) | |||
10-113876617-A-C | Fibrosis, neurodegeneration, and cerebral angiomatosis | Pathogenic (Sep 20, 2021) | ||
10-113876622-A-G | Inborn genetic diseases | Likely benign (Jun 17, 2022) | ||
10-113876631-G-T | Fibrosis, neurodegeneration, and cerebral angiomatosis | Pathogenic (May 16, 2023) | ||
10-113876643-A-G | Inborn genetic diseases | Uncertain significance (Jan 27, 2022) | ||
10-113876696-A-T | NHLRC2-related disorder | Likely benign (Dec 09, 2019) | ||
10-113876734-G-A | Inborn genetic diseases | Uncertain significance (Jun 24, 2022) | ||
10-113876742-G-A | Fibrosis, neurodegeneration, and cerebral angiomatosis | Uncertain significance (Jan 09, 2024) | ||
10-113876766-A-G | Inborn genetic diseases | Uncertain significance (Feb 22, 2023) | ||
10-113876789-CAG-C | Fibrosis, neurodegeneration, and cerebral angiomatosis | Pathogenic (Jan 14, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NHLRC2 | protein_coding | protein_coding | ENST00000369301 | 11 | 62534 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000832 | 0.999 | 125703 | 0 | 42 | 125745 | 0.000167 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.742 | 328 | 368 | 0.891 | 0.0000169 | 4705 |
Missense in Polyphen | 70 | 112.77 | 0.62074 | 1468 | ||
Synonymous | 0.0897 | 137 | 138 | 0.990 | 0.00000674 | 1420 |
Loss of Function | 2.95 | 14 | 32.0 | 0.437 | 0.00000148 | 425 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000204 | 0.000204 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.0000463 | 0.0000462 |
European (Non-Finnish) | 0.000257 | 0.000255 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.0000991 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Pathway
- Platelet degranulation ;Response to elevated platelet cytosolic Ca2+;Platelet activation, signaling and aggregation;Hemostasis
(Consensus)
Recessive Scores
- pRec
- 0.0994
Intolerance Scores
- loftool
- 0.467
- rvis_EVS
- 0.67
- rvis_percentile_EVS
- 84.61
Haploinsufficiency Scores
- pHI
- 0.0847
- hipred
- N
- hipred_score
- 0.426
- ghis
- 0.507
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.294
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Nhlrc2
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Zebrafish Information Network
- Gene name
- nhlrc2
- Affected structure
- midbrain
- Phenotype tag
- abnormal
- Phenotype quality
- vacuolated
Gene ontology
- Biological process
- platelet degranulation;cell redox homeostasis
- Cellular component
- extracellular region;platelet alpha granule lumen
- Molecular function
- protein binding